Merck & Co. Achieve Fivefold Performance Increase for Critical Research Platform
sponsored by Oracle Corporation UK Ltd

As the volume of data continues to grow, many companies are finding that legacy database platforms lack the necessary scalability, agility, and performance for today’s market. Merck & Co., a global research-driven pharmaceutical company, was experiencing such extreme growth in their database that application performance was starting to suffer.

Download this case study to uncover how Merck & Co. overcame their database dilemma by implementing an innovative platform that enabled them to:

  • Reduce memory utilization by 40%
  • Increase system speed by 5x
  • Increase efficiency
  • And more.
(THIS RESOURCE IS NO LONGER AVAILABLE.)
 
Available Resources from Oracle Corporation UK Ltd
See what other users are reading via our Daily Top 50 Report
.

About TechTarget:

TechTarget provides enterprise IT professionals with the information they need to perform their jobs - from developing strategy, to making cost-effective IT purchase decisions and managing their organizations' IT projects - with its network of technology-specific Web sites, events and magazines

All Rights Reserved, Copyright 2000 - 2014, TechTarget | Read our Privacy Statement